Read More Pharma Industry News Bausch + Lomb completes XIIDRA acquisition to fortify dry eye offering Bausch + Lomb Corporation (NYSE/TSX: BLCO), a prominent global eye health company, has successfully wrapped up its acquisition… byPallavi MadhirajuOctober 1, 2023